ExchangeDEX+

Buy Crypto Markets Spot FuturesGOLD Earn Event Center

Commodity Zero-Fee Gala

CRISPR Therapeutics AG (CRSP)

NASDAQ

$48.93

$+0.58

(+1.20%)

CRISPR Therapeutics AG (CRSP) Live Price Chart

Page last updated: 2026-02-12 21:38:00

Key Market Data

Market Cap	$4.66B
Open	$48.66
High	$220.20
Low	$11.63
Previous Close	$48.32
Price Change	$+0.58
Percentage Change	+1.20%
Volume	2M

CRISPR Therapeutics AG (CRSP) Stock Price Today

CRISPR Therapeutics AG (CRSP) is currently trading at $48.93 as of 2026-02-12 21:38:00, reflecting a +1.20% move ($+0.58) from the previous close.

In the short term, the stock has returned -1,399.19% over the past four weeks. Over the last 12 months, CRISPR Therapeutics AG has recorded a +13.00% price change, indicating a stable performance relative to the broader market.

CRISPR Therapeutics AG (CRSP) 7-Day Stock Price Changes

Over the past seven days, CRISPR Therapeutics AG has traded within a short-term range shaped by market sentiment in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. During this period, the stock moved from its previous closing price of $47.22 to the latest recorded price of $48.93, reflecting an intraday change of +1.20%. Daily movements highlight shifts in trading volume (1,519,963), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, CRSP has delivered a -1,399.19% return over the past month and a +13.00% change in the last 12 months, indicating a stable trend relative to its broader sector peers.

How to Buy CRISPR Therapeutics AG (CRSP)

You can buy and trade CRSP on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for CRSP and Execute Your Trade

Open the trading page, enter CRSP in the search bar, select the amount of CRSP you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is CRISPR Therapeutics AG (CRSP)?

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

CRISPR Therapeutics AG Information

Industry	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Employees	393
Sector	BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Company Website	https://www.crisprtx.com

Frequently Asked Questions (FAQ)

1.What is the current share price of CRISPR Therapeutics AG?

The latest trading price for CRISPR Therapeutics AG (Common Stock) is $ 48.93, compared with a previous closing price of $ 48.32. That means the stock has moved +1.20% so far today. Intraday price updates and recent trading activity for CRSP can be tracked on the live chart and quote section on this page.

2.Is CRISPR Therapeutics AG stock going up or down?

Looking at recent performances, CRSP has returned -1,399.19% over the past month, -15.04% over the last six months and +13.00% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe stable price momentum for CRISPR Therapeutics AG stock, but keep in mind that past returns do not guarantee future results.

3.Where does CRSP currently sit relative to its 52-week high and low?

In the most recent 52-week period, CRISPR Therapeutics AG has traded between a low of $ 30.04 and a high of $ 78.48. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether CRSP is currently nearer the top or the bottom of its one-year trading band.

4.How is CRISPR Therapeutics AG classified by sector and industry?

CRISPR Therapeutics AG is classified in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. In practice, this means CRISPR Therapeutics AG is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing CRSP’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector could influence CRISPR Therapeutics AG’s performance.

5.Where is CRISPR Therapeutics AG listed and how large is it by market value?

CRISPR Therapeutics AG is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 4.66B, the company is classified as a Mid-cap stock. Market cap gives a quick sense of CRISPR Therapeutics AG's size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does CRSP's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -5.12 summarises how much profit CRISPR Therapeutics AG has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track CRISPR Therapeutics AG's financial performance over time?

To follow CRISPR Therapeutics AG's financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how CRSP is performing and how the market is responding.

8.When is CRISPR Therapeutics AG expected to report earnings?

CRISPR Therapeutics AG's next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for CRSP, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in CRISPR Therapeutics AG's earnings reports?

CRISPR Therapeutics AG's earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether CRSP is meeting, beating or missing expectations.

10.How can I stay informed about CRISPR Therapeutics AG's results and guidance?

You can stay up to date on CRISPR Therapeutics AG by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for CRSP on this page helps you see how new information is being reflected in the stock.

11.Does CRISPR Therapeutics AG pay a regular cash dividend to its shareholders?

CRISPR Therapeutics AG Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor CRSP's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for CRSP?

Based on the latest earnings data, CRSP has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether CRISPR Therapeutics AG is an attractive income stock. The dividend payout ratio measures what percentage of earnings CRISPR Therapeutics AG distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is CRISPR Therapeutics AG?

CRISPR Therapeutics AG is a publicly traded company in the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) industry within the BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is CRSP valued in terms of P/E ratio and EPS?

CRISPR Therapeutics AG currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -5.12. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of CRISPR Therapeutics AG's earnings. Comparing CRSP's P/E and EPS to those of other BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as CRISPR Therapeutics AG

The Walt Disney Company

DIS

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Franklin Resources, Inc.

BEN

ChargePoint Holdings, Inc.

CHPT

Entergy Corporation

ETR

Goldman Sachs Group Inc.

Millrose Properties, Inc.

MRP

Top Gainers

Browse today's leading gainers in the US stock market

Haoxin Holdings Limited

HXHX

IPG Photonics Corporation

IPGP

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

SOL

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

CRSP-to-USD Calculator

Amount

CRSP

USD

1 CRSP = 48.93 USD